메뉴 건너뛰기




Volumn 35, Issue 3, 2008, Pages 421-429

Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status

Author keywords

Apoptosis; Arsenic trioxide; cDNA microarray; Cell cycle; Glioma; p53

Indexed keywords

ARSENIC TRIOXIDE; COMPLEMENTARY DNA; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR;

EID: 48249130079     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-007-9102-6     Document Type: Article
Times cited : (37)

References (28)
  • 2
    • 0033023072 scopus 로고    scopus 로고
    • New treatment strategies for malignant gliomas.
    • 3
    • NG Avgeropoulos TT Batchelor 1999 New treatment strategies for malignant gliomas. Oncologist 4 3 209 224
    • (1999) Oncologist , vol.4 , pp. 209-224
    • Avgeropoulos, N.G.1    Batchelor, T.T.2
  • 3
    • 0035031195 scopus 로고    scopus 로고
    • Introduction: The history of arsenic trioxide in cancer therapy.
    • S2
    • KH Antman 2001 Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6 S2 1 2
    • (2001) Oncologist , vol.6 , pp. 1-2
    • Antman, K.H.1
  • 4
    • 0348014917 scopus 로고    scopus 로고
    • Arsenic trioxide enhances radiation response of 9L glioma in the rat brain.
    • 6
    • JH Kim YS Lew A Kolozsvary 2003 Arsenic trioxide enhances radiation response of 9L glioma in the rat brain. Radiat Res 160 6 662 666
    • (2003) Radiat Res , vol.160 , pp. 662-666
    • Kim, J.H.1    Lew, Y.S.2    Kolozsvary, A.3
  • 5
    • 4444346338 scopus 로고    scopus 로고
    • Increased cure rate of glioma using concurrent therapy with radiotherapy and arsenic trioxide.
    • 1
    • S Ning SJ Knox 2004 Increased cure rate of glioma using concurrent therapy with radiotherapy and arsenic trioxide. Int J Radiation Oncology Biol Phys 60 1 197 203
    • (2004) Int J Radiation Oncology Biol Phys , vol.60 , pp. 197-203
    • Ning, S.1    Knox, S.J.2
  • 6
    • 0032933610 scopus 로고    scopus 로고
    • Malignant cells can be sensitised to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    • 1
    • J Dai SR Weinberg S Waxman Y Jing 1999 Malignant cells can be sensitised to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93 1 268 277
    • (1999) Blood , vol.93 , pp. 268-277
    • Dai, J.1    Weinberg, S.R.2    Waxman, S.3    Jing, Y.4
  • 7
    • 0031657760 scopus 로고    scopus 로고
    • Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis.
    • 2
    • YC Chen SY Lin-shiau JK Lin 1998 Involvement of reactive oxygen species and caspase 3 activation in arsenic-induced apoptosis. J Cell Physiol 177 2 324 333
    • (1998) J Cell Physiol , vol.177 , pp. 324-333
    • Chen, Y.C.1    Lin-Shiau, S.Y.2    Lin, J.K.3
  • 8
    • 0034212785 scopus 로고    scopus 로고
    • Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    • 11
    • WH Park JG Seol ES Kim 2000 Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60 11 3065 3071
    • (2000) Cancer Res , vol.60 , pp. 3065-3071
    • Park, W.H.1    Seol, J.G.2    Kim, E.S.3
  • 9
    • 0033526358 scopus 로고    scopus 로고
    • Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    • 9
    • XH Zhu YL Shen YK Jing 1999 Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst 91 9 772 778
    • (1999) J Natl Cancer Inst , vol.91 , pp. 772-778
    • Zhu, X.H.1    Shen, Y.L.2    Jing, Y.K.3
  • 10
    • 0038743077 scopus 로고    scopus 로고
    • Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
    • 9
    • T Kanzawa Y Kondo H Ito 2003 Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63 9 2103 2108
    • (2003) Cancer Res , vol.63 , pp. 2103-2108
    • Kanzawa, T.1    Kondo, Y.2    Ito, H.3
  • 11
    • 13944256602 scopus 로고    scopus 로고
    • Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    • 6
    • T Kanzawa L Zhang L Xiao 2005 Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24 6 980 991
    • (2005) Oncogene , vol.24 , pp. 980-991
    • Kanzawa, T.1    Zhang, L.2    Xiao, L.3
  • 12
    • 0036653125 scopus 로고    scopus 로고
    • Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioma cell lines differing in p53 status.
    • 1
    • S Zhao T Tsuchida K Kawakami 2002 Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioma cell lines differing in p53 status. Int J Oncol 21 1 49 55
    • (2002) Int J Oncol , vol.21 , pp. 49-55
    • Zhao, S.1    Tsuchida, T.2    Kawakami, K.3
  • 13
    • 0026777319 scopus 로고
    • Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioma cell.
    • 8
    • SJ Ullrich WE Mercer E Appella 1992 Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioma cell. Oncogene 7 8 1635 1643
    • (1992) Oncogene , vol.7 , pp. 1635-1643
    • Ullrich, S.J.1    Mercer, W.E.2    Appella, E.3
  • 16
    • 9244224723 scopus 로고    scopus 로고
    • Intrinsic tumor suppression.
    • 7015
    • SW Lowe E Cepero G Evan 2004 Intrinsic tumor suppression. Nature 432 7015 307 315
    • (2004) Nature , vol.432 , pp. 307-315
    • Lowe, S.W.1    Cepero, E.2    Evan, G.3
  • 17
    • 0030768779 scopus 로고    scopus 로고
    • Regulation of transcription by proteins that control cell cycle.
    • 6647
    • BD Dynlacht 1997 Regulation of transcription by proteins that control cell cycle. Nature 389 6647 149 152
    • (1997) Nature , vol.389 , pp. 149-152
    • Dynlacht, B.D.1
  • 18
    • 0035810054 scopus 로고    scopus 로고
    • Regulation of the G2/M transition by p53.
    • 15
    • WR Taylor GR Stark 2001 Regulation of the G2/M transition by p53. Oncogene 20 15 1803 1815
    • (2001) Oncogene , vol.20 , pp. 1803-1815
    • Taylor, W.R.1    Stark, G.R.2
  • 19
    • 0033066323 scopus 로고    scopus 로고
    • Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase3 in vitro.
    • 1-2
    • Y Akao Y Nakagawa K Akiyama 1999 Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase3 in vitro. FEBS Lett 455 1-2 59 62
    • (1999) FEBS Lett , vol.455 , pp. 59-62
    • Akao, Y.1    Nakagawa, Y.2    Akiyama, K.3
  • 20
    • 10844264632 scopus 로고    scopus 로고
    • Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: Reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria.
    • 24
    • YH Kang MJ Yi MJ Kim 2004 Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly (ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 64 24 8960 8967
    • (2004) Cancer Res , vol.64 , pp. 8960-8967
    • Kang, Y.H.1    Yi, M.J.2    Kim, M.J.3
  • 21
    • 0034490080 scopus 로고    scopus 로고
    • Arsenic Trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian cell lines.
    • 12
    • R Uslu UA Sanli C Sezgin 2000 Arsenic Trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian cell lines. Clin Cancer Res 61 12 4957 4964
    • (2000) Clin Cancer Res , vol.61 , pp. 4957-4964
    • Uslu, R.1    Sanli, U.A.2    Sezgin, C.3
  • 22
    • 0035879016 scopus 로고    scopus 로고
    • Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    • 14
    • H Maeda S Hori H Nishitoh 2001 Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61 14 5432 5440
    • (2001) Cancer Res , vol.61 , pp. 5432-5440
    • Maeda, H.1    Hori, S.2    Nishitoh, H.3
  • 23
    • 0037192453 scopus 로고    scopus 로고
    • Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines.
    • 19
    • Y Nakagawa Y Akao H Morikawa 2002 Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci 70 19 2253 2262
    • (2002) Life Sci , vol.70 , pp. 2253-2262
    • Nakagawa, Y.1    Akao, Y.2    Morikawa, H.3
  • 24
    • 0036295558 scopus 로고    scopus 로고
    • Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    • 4
    • M Kito Y Akao N Ohishi 2002 Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 291 4 861 867
    • (2002) Biochem Biophys Res Commun , vol.291 , pp. 861-867
    • Kito, M.1    Akao, Y.2    Ohishi, N.3
  • 25
    • 0032773828 scopus 로고    scopus 로고
    • Induction of apoptosis and inhibition of human gastric cancer MCG-803 cell growth by arsenic trioxide.
    • 8
    • TC Zhang EH Cao JF Li 1999 Induction of apoptosis and inhibition of human gastric cancer MCG-803 cell growth by arsenic trioxide. Eur J Cancer 35 8 1258 1263
    • (1999) Eur J Cancer , vol.35 , pp. 1258-1263
    • Zhang, T.C.1    Cao, E.H.2    Li, J.F.3
  • 26
    • 0036250205 scopus 로고    scopus 로고
    • Arsenic trioxide as a novel anticancer agent against human transitional carcinoma characterizing its apoptotic pathway.
    • 3
    • YS Pu TC Hour J Chen 2002 Arsenic trioxide as a novel anticancer agent against human transitional carcinoma characterizing its apoptotic pathway. Anticancer Drugs 13 3 293 300
    • (2002) Anticancer Drugs , vol.13 , pp. 293-300
    • Pu, Y.S.1    Hour, T.C.2    Chen, J.3
  • 27
    • 0033787018 scopus 로고    scopus 로고
    • Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro.
    • 5
    • HY Yu YL Yang YY Gao 2000 Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro. World J Gastroenterol 6 5 681 687
    • (2000) World J Gastroenterol , vol.6 , pp. 681-687
    • Yu, H.Y.1    Yang, Y.L.2    Gao, Y.Y.3
  • 28
    • 0035874054 scopus 로고    scopus 로고
    • Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide.
    • 4
    • K Iwama S Nakajo T Aiuchi K Nakaya 2001 Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the Ca2+-dependent production of superoxide. Int J Cancer 92 4 518 526
    • (2001) Int J Cancer , vol.92 , pp. 518-526
    • Iwama, K.1    Nakajo, S.2    Aiuchi, T.3    Nakaya, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.